Retinal Degeneration Fund
Overview
The Retinal Degeneration Fund (RD Fund) is the venture philanthropy arm of the Foundation Fighting Blindness, making mission-related investments in companies developing treatments and cures for inherited retinal diseases and dry age-related macular degeneration.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beacon Therapeutics | Jan 2026 | Series C | Co-investor |
| Perceive Pharma | Feb 2025 | Series A | Co-investor |
| Perceive Bio | Jan 2023 | Series B | - |
| SparingVision | Sep 2022 | Series B | Co-investor |
| Nacuity Pharmaceuticals, Inc. | Jun 2022 | Series B | - |
For institutional investors. Book with your work email.
Key People
Maureen Okereke
Chief Executive Officer
Rusty Kelley
Managing Director, Senior Vice President, Investments And Alliances
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Retinal Degeneration Fund based?
Retinal Degeneration Fund is headquartered in Raleigh, North Carolina, United States.
When was Retinal Degeneration Fund founded?
Retinal Degeneration Fund was founded in 2018.
How many portfolio companies does Retinal Degeneration Fund have?
Retinal Degeneration Fund has 11 portfolio companies in Caplight's dataset.
What are some companies in Retinal Degeneration Fund's portfolio?
Recent investments visible on Caplight include Beacon Therapeutics, Perceive Pharma, Perceive Bio, SparingVision, Nacuity Pharmaceuticals, Inc..
What was Retinal Degeneration Fund's most recent investment?
Retinal Degeneration Fund's most recent investment on Caplight was in Beacon Therapeutics in 2026.
What sectors does Retinal Degeneration Fund focus on?
Retinal Degeneration Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Retinal Degeneration Fund focus on?
Retinal Degeneration Fund typically invests at the Early stage.
What is Retinal Degeneration Fund's AUM?
Retinal Degeneration Fund's assets under management are estimated between $122.0M and $122.0M.